Drug or treatment

Ligufalimab clinical trials

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Ivonescimab with or without ligufalimab versus pembrolizumab as first-line treatment for recurrent/metastatic PD-L1-positive head and neck squamous cell carcinoma

  This study tests whether ivonescimab alone or with ligufalimab works as a first-line treatment for PD-L1‑positive recurrent or metastatic head and neck cancer, compared with pembrolizumab.

  Recruiting Phase 3 Groupe Oncologie Radiotherapie Tete et Cou · Le Havre · NCT07264075

• Combining Ligufalimab and Cadonilimab for Advanced Liver Cancers

  This study is testing if combining two treatments, Ligufalimab and Cadonilimab, can help people with advanced liver cancers that haven't improved with other therapies.

  Recruiting Phase 2 University of Texas Southwestern Medical Center · Dallas, Texas · NCT06789848

Quick answers

How many clinical trials of Ligufalimab are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →